healthcare professionals / regulatory systems / biopharmaceutical industry / medicinal products / research-based pharmaceutical industries / /
MedicalTreatment
innovative therapies / /
Organization
Duke University / World Health Organisation / Europe Union / N/A committee / European Commission / European Federation of Pharmaceutical Industries and Associations / European Union / European Parliament / Univ of California / World Medical Association / Johns Hopkins Bloomberg School of Public / /
27 November[removed]EFPIA position on Clinical Trials Regulation trialogue As the revision of the Clinical Trial Directive enters the Trialogue phase, it is critical to remember that the key objective of this legislation p